Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review

J J Swigris, W G Kuschner, S S Jacobs, S R Wilson, M K Gould, J J Swigris, W G Kuschner, S S Jacobs, S R Wilson, M K Gould

Abstract

Background: Idiopathic pulmonary fibrosis (IPF) profoundly affects the quality of patients' lives. A systematic review was performed to evaluate critically the published literature and to examine what is known about health-related quality of life (HRQL) in patients with IPF.

Methods: The MEDLINE, EMBASE, Health and Psychosocial Instruments, and Cochrane Library databases were searched to 1 April 2004. Abstracts and bibliographies of published articles were scanned and contact was made with investigators. Included studies analysed HRQL (or quality of life) in at least 10 patients with IPF. Two reviewers independently selected studies, evaluated their quality according to predetermined criteria, and abstracted data on study design, patients' demographic and clinical characteristics, and quality of life outcome measures.

Results: Seven studies met the inclusion criteria. The studies enrolled 512 patients with IPF and used three different instruments to measure HRQL. All studies had important limitations in methodological quality; none measured longitudinal changes in HRQL over time. Patients reported substantially impaired HRQL, especially in domains that measured physical health and level of independence. Patients with IPF appear to have similar impairments in HRQL to those with chronic obstructive pulmonary disease. Measures of dyspnoea were moderately correlated with scores from domains that measured physical health (R2 = 0.03-0.66) and energy/fatigue/pep (R2 = 0.19-0.55), but measures of pulmonary function and gas exchange did not correlate as strongly with these and other domains.

Conclusion: Studies of HRQL in patients with IPF suggest that, in addition to the obvious effect on physical health, general health, energy level, respiratory symptoms, and level of independence are also impaired. Variability in HRQL among patients is not fully explained by measures of dyspnoea or pulmonary function, suggesting that HRQL measures provide unique information. More research is needed to identify or design appropriate measurement instruments for patients with IPF and to examine changes in HRQL over time or in response to specific treatments.

References

    1. Chest. 1999 Nov;116(5):1175-82
    1. N Engl J Med. 2005 May 12;352(19):1967-76
    1. Am J Respir Crit Care Med. 2001 Jan;163(1):122-8
    1. Am J Med. 2001 Mar;110(4):278-82
    1. Thorax. 2001 Jun;56(6):482-6
    1. Eur Respir J. 2001 May;17(5):954-61
    1. Eur Respir J. 2002 Feb;19(2):209-16
    1. Respir Med. 2000 Mar;94(3):273-8
    1. Eur J Cancer. 2002 Sep;38(14):1824-31
    1. Cancer. 2003 Jan 15;97(2):377-88
    1. N Engl J Med. 2004 Jan 8;350(2):125-33
    1. Am J Med. 1990 Apr;88(4):396-404
    1. Ann Intern Med. 1993 Apr 15;118(8):622-9
    1. Thorax. 1994 Feb;49(2):162-70
    1. Am J Respir Crit Care Med. 1994 Oct;150(4):967-72
    1. Qual Life Res. 1995 Aug;4(4):293-307
    1. J Heart Lung Transplant. 1995 Sep-Oct;14(5):870-7
    1. Ann Intern Med. 1997 Sep 1;127(5):380-7
    1. Ann Intern Med. 1997 Oct 1;127(7):531-7
    1. Am J Respir Crit Care Med. 1998 Jul;158(1):220-5
    1. Respir Med. 2005 Apr;99(4):408-14
    1. Chest. 2000 Jun;117(6):1627-32

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever